Meta-analysis of 16 RCTs (3598 patients) with comorbid asthma and chronic rhinosinusitis with nasal polyps: biologics cut asthma exacerbations by 73% (rate ratio 0.27) and improved FEV1, asthma control and nasal polyp scores, with a favourable safety profile.
Meta-analysisn = 3,598
Kyriakopoulos et al. Efficacy of biologic agents in patients with comorbid asthma and chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis of randomised controlled trials